A Crystal Ball for Cancer Survivors
This test can be thought of as a crystal ball for cancer survivors and research has found it can predict with near certainty whether a patient’s cancer will recur. So why aren't more patients getting the test?
An Omic Vision of a Diagnostic / Prognostic Future?
An article by Chen et al., published recently in the journal Cell, offers us what Eric Topol has already dubbed “panor-omic” insight into a potential future — one in which our genomic data can be cross-correlated against other “omic” data (including transcriptomic, proteomic, metabolomic, and autoantibody profiles) to give individualized insights into our current clinical […]
Solving Healthcare’s Provider Data Problem Starts with Interoperability
Break down the silos. Take control of your provider data.